Prognostic significance of natural products against multidrug tumor resistance

Pankaj Garg1, Rachana Garg2, David Horne3

  • 1Department of Chemistry, GLA University, Mathura, Uttar Pradesh, 281406, India.

Cancer Letters
|February 3, 2023
PubMed

Insights

Natural dietary products offer a promising avenue for cancer prevention and management. Bioactive ingredients in these products show potential in combating various malignancies, complementing traditional treatments.

Area of Science:

  • Oncology
  • Nutritional Science
  • Pharmacology

Background:

  • Cancer is a leading global cause of mortality, with increasing incidence despite advances in conventional treatments.
  • Current cancer therapies (surgery, radiation, pharmaceuticals) have limitations in reducing mortality rates.
  • Natural products are increasingly explored as complementary or alternative strategies for cancer prevention and treatment.

Purpose of the Study:

  • To review the mechanisms of action of bioactive compounds from natural dietary products.
  • To explore the potential of these natural compounds in cancer prevention and management.
  • To highlight the role of primary prevention in global cancer control.

Main Methods:

  • Literature review of scientific studies on natural products and cancer.
  • Analysis of bioactive ingredients in dietary products.
  • Examination of proposed mechanisms of action against various cancers.

Main Results:

  • A significant proportion of current medications are derived from natural plant products.
  • Bioactive ingredients in natural dietary products exhibit diverse mechanisms against cancer.
  • Natural products show promise in both primary cancer prevention and as adjuncts in management.

Conclusions:

  • Natural product-based therapies represent a viable alternative or complementary approach to cancer treatment.
  • Dietary bioactive compounds hold significant potential for cancer prevention and management strategies.
  • Further research into natural products is crucial for advancing cancer control efforts.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.4K